Articles From: Cliffs Natural Resources Inc. Announces Quarterly Conference Call for Third-Quarter Financial Results on October 28, 2014 to Clorox Declares Regular Quarterly Dividend of 74 Cents per Share


CLEVELAND , Sept.
Sign-up for Cliffs Natural Resources Inc. Appoints Michael Siegal to Board of Directors investment picks
CLEVELAND , Oct.
Sign-up for Cliffs Natural Resources Inc. Appoints Susan Green to Board of Directors investment picks
CLEVELAND , Sept.
Sign-up for Cliffs Natural Resources Inc. Reports on Sustainability Progress investment picks
- Reports Adjusted EBITDA1 of $233 million and Adjusted Earnings2 of $0.21 per diluted share - Reports Realized Pricing of $101 Per Ton in U.S. Iron Ore in Q3 2014 - Cash Cost Per Ton Rate Improves Across All Business Segments Compared to Q2 2014 - Reports Net Debt Reduction of $100 Million from Q2 2014 CLEVELAND , Oct.
Sign-up for Cliffs Natural Resources Inc. Reports Third-Quarter Results investment picks
Cliffs Natural Resources Inc. to Pursue Exit Options for its Eastern Canadian Operations Canada NewsWire CLEVELAND , Nov.
Sign-up for Cliffs Natural Resources Inc. to Pursue Exit Options for its Eastern Canadian Operations investment picks
2014/11/3
Clifton Bancorp Inc. (NasdaqGS:CSBK), the holding company for Clifton Savings Bank, today announced results for the second quarter ended September 30, 2014.
Sign-up for Clifton Bancorp Inc. Announces Financial Results for the Second Quarter Ended September 30, 2014 investment picks
2014/11/5
Clifton Bancorp Inc. (the “Company”) (NasdaqGS: CSBK), the parent company of Clifton Savings Bank, announced today that the Company will pay a cash dividend of $0.06 per common share for the quarter ended September 30, 2014.
Sign-up for Clifton Bancorp Inc. Declares Cash Dividend investment picks
AVEO Oncology (NASDAQ:AVEO) today announced that clinical data on ficlatuzumab, the Company’s hepatocyte growth factor (HGF) inhibitory antibody, as well as tivozanib, the Company’s inhibitor of vascular endothelial growth factor (VEGF) 1, 2, and 3 receptors, will be presented at the European Society of Medical Oncology (ESMO) 2014 Congress in Madrid, Spain, September 26 – September 30, 2014.
Sign-up for Clinical Data on AVEO Oncology’s Ficlatuzumab and Tivozanib to Be Presented at the ESMO 2014 Congress investment picks
2014/11/13
FARMINGDALE, N.Y. , Nov.
Sign-up for Clinical Paper on Treatment of Burns Highlights Effectiveness of Misonix SonicOne in Burn Center Operating Room investment picks
BRAF V600E assay improves determination of mutational status and allows monitoring of treatment response SAN DIEGO , Oct.
Sign-up for Clinical Performance of Trovagene's Precision Cancer Monitoring Platform Presented at Second Annual International ECD Medical Symposium investment picks
2014/12/4
The LuViva® Advanced Cervical Scan continues to demonstrate the capability to screen the general population for cervical cancer and to eliminate unnecessary testing for women who are screened by other methods, according to recent studies presented at the 25 th Turkish Society of Gynecology Oncology Congress.
Sign-up for Clinical Results Presented at Turkish Medical Congress Further Support LuViva® Advanced Cervical Scan for Primary Screening and Detection of Cervical Cancer investment picks
Prospective blinded study demonstrates ability to accurately determine mutational status and monitor response to BRAF inhibitor therapy from urinary cell-free DNA SAN DIEGO , Oct.
Sign-up for Clinical Study Using Trovagene's Precision Cancer Monitoring Platform Published in Cancer Discovery investment picks
Clinigen Group plc (‘Clinigen’ or the ‘Group’, AIM:CLIN) the global specialty pharmaceutical company, today announces that it has received the first Drug Shortage Assistance Award from the US Food and Drug Administration (FDA) in recognition of its contribution in addressing a US shortage of Foscavir® (foscarnet sodium) injection.
Sign-up for Clinigen Group plc Receives FDA’s First Ever Drug Shortage Assistance Award investment picks
2014/9/24
Clinigen Group plc (‘Clinigen’ or the ‘Group’, AIM: CLIN), the global specialty pharmaceuticals business, has today published its preliminary results for the 12 months ended 30 June 2014.
Sign-up for Clinigen Group plc: Underlying EBITDA up 19.8% and EPS up 22% investment picks
Believes Business Combination could be achieved at a CSS share price of up to $34.00 NEW YORK , Nov.
Sign-up for Clinton Group Believes Merger Of CSS Industries And EveryWare Global Is In Best Interest Of All Shareholders investment picks
NEW YORK , Oct.
Sign-up for Clinton Group Calls On Nutrisystem To Sell Itself investment picks
NEW YORK , Nov.
Sign-up for Clinton Group Highlights The Options Available To Wet Seal Today investment picks
http://media.marketwire.com/attachments/201009/645481_CLXlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1148374&ProfileId=051205&sourceType=1 OAKLAND, CA --
Sign-up for Clorox Announces Oct. 31 Webcast of First-Quarter Fiscal Year 2015 Results investment picks
http://media.marketwire.com/attachments/201009/645481_CLXlogo.jpg http://at.marketwire.com/accesstracking/AccessTrackingLogServlet?PrId=1144768&ProfileId=051205&sourceType=1 OAKLAND, CA --
Sign-up for Clorox Declares Regular Quarterly Dividend of 74 Cents per Share investment picks
Go Premium!
Exclusive Premium Member Benefits
Get the best thinking of 150+ disciplined
objective, experienced analysts-dedicated to
specific industries and securities.
+2,500 Analyst Reports
Wide Moat Screener for Stocks
Medalist Screener for Funds
Premium Portfolio Manager with X-Ray & Monitor
Premium eNewsletters
Morningstar Basic Benefits (All)
Sign up now - No charge for the first 14 days
Articles From: Cliffs Natural Resources Inc. Announces Quarterly Conference Call for Third-Quarter Financial Results on October 28, 2014 to Clorox Declares Regular Quarterly Dividend of 74 Cents per Share
Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol |  Title Star Rating |  Category |  Total Assets |  Top Holdings |  Top Sectors |  Symbol |  Name Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Star Rating |  Market Cap |  Stock Type |  Sector |  Industry Star Rating |  Investment Style |  Total Assets |  Category |  Top Holdings |  Top Sectors |  Symbol / Ticker |  Title Star Rating |  Category |  Total Assets |  Symbol / Ticker |  Name Title |  Date |  Author |  Collection |  Popularity |  Interest Title |  Date |  Company |  Symbol |  Interest |  Popularity Title |  Date |  Company |  Symbol |  Interest |  Popularity Topic |  Sector |  Key Indicators |  User Interest |  Market Cap |  Industry Name |  Ticker |  Popularity |  Our Choices |  Most Recent